Home › Funds › MB, LEVIS & ASSOCIATES, LLC › IBDX

MB, LEVIS & ASSOCIATES, LLC position in IBDX

ISHARES TR

MB, LEVIS & ASSOCIATES, LLC reported holding 281,695 shares of IBDX (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 2.49% of its reported portfolio and ranking #13 among its reported holdings. MB, LEVIS & ASSOCIATES, LLC has disclosed IBDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)281.69K sh
Reported value held$6.78M
Portfolio Weight2.49%
First reportedQ3 2023
Last changeReduce
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How MB, LEVIS & ASSOCIATES, LLC's IBDX position evolved

MB, LEVIS & ASSOCIATES, LLC first disclosed a stake in IBDX in Q3 2023 at 394,881 shares (US$9.3M). The position peaked in Q2 2026 at 527,546 shares, worth US$13.3M. Across 13 filings, MB, LEVIS & ASSOCIATES, LLC increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 281,695 shares valued at US$6.8M — a reduction of -245,851 shares quarter over quarter.. Notable position changes include a 47% trim in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 394.88K $9.27M New
Q4 2023 435.00K $10.97M Add
Q1 2024 450.61K $11.18M Add
Q2 2024 465.47K $11.43M Add
Q3 2024 475.54K $12.23M Add
Q4 2024 484.96K $11.92M Add
Q1 2025 491.15K $12.27M Add
Q2 2025 503.04K $12.72M Add
Q3 2025 505.92K $12.96M Add
Q4 2025 512.99K $13.10M Add
Q1 2026 521.22K $13.17M Add
Q2 2026 527.55K $13.29M Add
Q3 2026 281.69K $6.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBDX and 13F data

IBDX (ISHARES TR) is a company whose sector is not yet classified in our data. 37 other funds we track also report a position in IBDX — the largest reported positions include Aptus Capital Advisors, LLC (US$162.6M), Capital Investment Advisors, LLC (US$88.3M), CAPITAL ADVISORS INC/OK (US$71.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBDX

All IBDX fund holders →

FAQ

How long has MB, LEVIS & ASSOCIATES, LLC held IBDX?

MB, LEVIS & ASSOCIATES, LLC has disclosed IBDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MB, LEVIS & ASSOCIATES, LLC's current position in IBDX?

As of Q3 2026, MB, LEVIS & ASSOCIATES, LLC holds 281.69K shares of IBDX (ISHARES TR), valued at $6.78M, representing 2.49% of its reported portfolio and ranking #13.

Has MB, LEVIS & ASSOCIATES, LLC been buying or selling IBDX?

In the latest 13F filing (Q3 2026), MB, LEVIS & ASSOCIATES, LLC reduced its position in IBDX. The position peaked in Q2 2026 at 527.55K shares.

Which other funds hold IBDX?

Other major institutional holders of IBDX include Aptus Capital Advisors, LLC, Capital Investment Advisors, LLC, CAPITAL ADVISORS INC/OK, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.